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Abstract
Sleep apnea (SA) causes long-lasting changes in neuronal circuitry, which persist even in patients successfully treated for the
acute effects of the disease. Evidence obtained from the intermittent hypoxia (IH) experimental model of SA has shown
neuronal death, impairment in learning and memory and reactive gliosis that may account for cognitive and structural
alterations observed in human patients. However, little is known about the mechanism controlling these deleterious effects
that may be useful as therapeutic targets in SA. The Receptor for Advanced Glycation End products (RAGE) and its
downstream effector Nuclear Factor Kappa B (NF-kB) have been related to neuronal death and astroglial conversion to the
pro-inflammatory neurodegenerative phenotype. RAGE expression and its ligand S100B were shown to be increased in
experimental models of SA. We here used dissociated mixed hippocampal cell cultures and male Wistar rats exposed to IH
cycles and observed that NF-kB is activated in glial cells and neurons after IH. To disclose the relative contribution of the
S100B/RAGE/NF-kB pathway to neuronal damage and reactive gliosis after IH we performed sequential loss of function
studies using RAGE or S100B neutralizing antibodies, a herpes simplex virus (HSV)-derived amplicon vector that induces the
expression of RAGEDcyto (dominant negative RAGE) and a chemical blocker of NF-kB. Our results show that NF-kB
activation peaks 3 days after IH exposure, and that RAGE or NF-kB blockage during this critical period significantly improves
neuronal survival and reduces reactive gliosis. Both in vitro and in vivo, S100B blockage altered reactive gliosis but did not
have significant effects on neuronal survival. We conclude that both RAGE and downstream NF-kB signaling are centrally
involved in the neuronal alterations found in SA models, and that blockage of these pathways is a tempting strategy for
preventing neuronal degeneration and reactive gliosis in SA.
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Introduction
Sleep apnea (SA) is a highly prevalent pathology in adult
humans. SA patients suffer a repeated and transient reduction in
oxygen tension, termed intermittent hypoxia (IH). The central
nervous system (CNS) is vulnerable to these hypoxic conditions,
and neurocognitive manifestations of SA include not only daytime
sleepiness, but also alterations in personality and impairment of
concentration, perception, memory, communication and learning
[1–5]. Continuous positive airway pressure therapy (CPAP)
reduces daytime sleepiness and the cardiovascular complications
of SA [6]. However, even in patients under CPAP, executive
dysfunction often persists, possibly as a consequence of structural
and functional alterations in brain neurocircuitry [7–9]. Further-
more, imaging studies have shown persistent structural alterations
in the hippocampus of SA patients [10].
Regarding experimental settings, neuronal alterations and
reactive gliosis have also been demonstrated in different paradigms
that model the SA-induced IH [11,12]. The cognitive impairments
found in animal studies are structurally related to changes in
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hippocampal and cortical areas [13–18]. The precise mechanisms
that lead to neuronal alterations are not fully understood, but
production of reactive oxygen species (ROS) during the reox-
ygenation period (reviewed in [19]), glutamate-induced excitotox-
icity [20] and inflammation [21,22] have all been implicated in the
development of the neuronal pathology.
Reactive astrogliosis is a general response of astrocytes to
different types of injury; this reaction may reduce neuronal
survival due to the secretion of pro-inflammatory cytokines, ROS
and nitric oxide (NO). The subsequent formation of the glial scar
also impedes neuronal reconnection (reviewed in [23,24]).
However, there are abundant data showing that reactive astrocytes
are beneficial for the recovery of CNS function. For example,
reactive astrocytes can produce energy substrates and trophic
factors for neurons and oligodendrocytes, act as free radicals and
glutamate scavengers, actively restore the blood-brain barrier,
promote neovascularization, restore CNS ionic homeostasis,
promote remyelination and stimulate neurogenesis from neural
stem cells (reviewed in [25–27]). It is now known that reactive
astrogliosis is a complex phenomenon leading to either pro-
survival or pro-inflammatory neurodegenerative responses, involv-
ing the activation of different sets of genes [28]. Thus, an
interesting target for facilitating neuroprotection in the injured
brain would be to control the extent of the glial pro-inflammatory
neurodegenerative response.
The cellular and molecular elements contributing to the
inflammation are those involved in the activation of the innate
immune response. The Receptor for Advanced Glycation End
products (RAGE) is a Pattern Recognition Receptor (PRR) that
participates in the innate immune response. Activation of this
process can be achieved by interaction of PRR with Damage
Associated Molecular Pattern (DAMP) proteins, and usually leads
to pro-inflammatory responses mediated by the NF-kB transcrip-
tion factor. RAGE activation by glial S100B, a DAMP released by
astrocytes after injury, leads either to neuronal survival or death,
depending on the level of NF-kB transcriptional activity [29] and
activates astrocytes, ultimately promoting a pro-inflammatory
response [30,31].
In IH experimental models, RAGE is expressed in hippocampal
and cortical areas related to the cognitive disorders expressed in
SA patients [11,22]. S100B levels have also been found increased
in SA patients [32,33]. In an attempt to understand the
participation of RAGE signaling and NF-kB role on neuronal
survival and reactive gliosis after IH, we here report the results of
loss of function studies in vitro and in vivo performed by blocking
different steps of the S100B/RAGE/NF-kB pathway. By using
RAGE blocking antibodies, chemical blockers of NF-kB activation
and by developing a HSV-derived amplicon vector that induces
the expression of a defective RAGE (RAGEDcyto), we have been
able to show that attenuation of the RAGE/NF-kB signaling leads
to an improved neuronal survival and to a reduced reactive gliosis
after IH exposure.
Materials and Methods
Materials
Antibodies were obtained from Sigma (mouse monoclonal anti-
S100B); Dako [rabbit polyclonal anti gliofibrillary acidic protein
(GFAP)]; Millipore [mouse monoclonal anti microtubule associ-
ated protein (MAP-2); mouse monoclonal anti-neuronal nuclei
(NeuN), mouse monoclonal anti-RAGE, mouse monoclonal anti-
GFP, mouse monoclonal anti-nuclear localization signal of p65
NF-kB subunit (p65NLS), rabbit polyclonal anti-p65 NF-kB
subunit]; Pierce (mouse monoclonal anti bIII-Tubulin) and ICN
Biomedicals (rabbit polyclonal anti-b-galactosidase). Secondary
biotinylated antibodies, streptavidin complex (Extravidin) used for
immunohistochemistry studies, 4-chloro-5-bromo-3-indolyl-b-ga-
lactoside (X-gal) and other chemicals were purchased from Sigma.
Secondary fluorescent antibodies were obtained from Jackson
ImmunoResearch (Baltimore Pike, West Groove, PA). All other
chemical substances were of analytical grade.
Animals
Adult male Wistar rats (200–250 g) and 3-day old rat pups
obtained from the animal facility of the School of Pharmacy and
Biochemistry (University of Buenos Aires) and adult male
transgenic mice expressing an NF-kB-LacZ reporter gene (30 g)
[34] from the Montreal Neurological Institute and Hospital
(Center for Neuronal Survival, McGill University) were used in
this study. Animals were housed in a controlled environment (12/
12-h light/dark cycle, controlled humidity and temperature, free
access to standard laboratory rat food and water). Animal care and
all procedures done for this experimental protocol were in
accordance with the NIH guidelines for the Care and Use of
Laboratory Animals, and the principles presented in the Guide-
lines for the Use of Animals in Neuroscience Research by the
Society for Neuroscience. Protocols were approved by the
CICUAL Animal Committee of the School of Medicine,
University of Buenos Aires.
Dissociated mixed hippocampal cell cultures
This procedure was performed according to Lee and Parpura
[35] with minor modifications. Hippocampi were obtained after
brain dissection of deeply anaesthetized 3-day old Wistar rats and
incubated for 1 h with papain (20 U/ml) at 37uC in 5% CO2.
Papain was removed and tissue was washed once in DMEM.
Hippocampi were mechanically dissociated with a fire-polished
glass serological pipette until no visible clamps remained. Cells
were plated onto poly-L-lysine-coated multiwell chambers and fed
with DMEM, 1% glutamine, 1% penicillin-streptomycin and 10%
fetal calf serum. Cultures were maintained at 37uC in a humidified
atmosphere with 5% CO2; 50% of the medium was replaced by
fresh medium every 3 days. This protocol was kindly provided by
Dr. Vladimir Parpura (UAB, USA). All experiments were
performed in cultured cells after for 9-11 days.
Exposure to Intermittent Hypoxia
The in vivo IH experiments were performed as described in
Aviles Reyes et al. [11]. Briefly, animals were randomly divided
into four experimental groups and placed into two identical plastic
normobaric chambers (8 L). During the light period, O2 was
reduced from 21% to 10% over 1 min, held at 10% for 5 min,
returned to 21% over 1 min, and held at 21% for 6 min. This
cycle was repeated continuously for 8 h, giving a minimum of five
hypoxic events per hour of sleep, in accordance with the clinical
definition of sleep apnea [6]. Groups exposed to IH were named
IH1, IH3, IH5 and IH10, representing animals that have
undergone exposure to IH for 1, 3, 5 and 10 days. Control
animals were housed for the same period in identical chambers
where the only source of gas was room air. O2 level in each
chamber was monitored continuously with an electrochemical
sensor connected to a digital oxymeter (PumpControl, Buenos
Aires, Argentina) and regulated by timer-controlled valves
connected to room air and to a N2 source equipped with
separated flow mixers.
The in vitro IH exposure was performed as described in Shan
et al. [36]. Briefly, dissociated mixed hippocampal cell cultures
were exposed to IH (cycles of normoxia: 21% O2, 5% CO2,
RAGE/NF-kB Pathway in Sleep Apnea
PLOS ONE | www.plosone.org 2 September 2014 | Volume 9 | Issue 9 | e107901
balance N2 for 25 min; and hypoxia: 0.1% O2, 5% CO2, balance
N2 for 35 min). Control cultures were kept under normoxia
conditions (21% O2, 5% CO2, balance N2). For the blocking
assays, final concentrations of the blocking agents were: anti-
RAGE 1 mg/ml, anti-S100B 1 mg/ml, BAY117082 2 mM, mouse
IgG control antibody 1 mg/ml, DMSO 0.02% (v/v) (vehicle for
BAY117082).
Surgery and Infusion Procedures
Rats were anaesthetized with ketamine/xylazine (90/10 mg/kg
ip) and 22G guide cannulae were implanted in the CA1 region of
the dorsal right hippocampus, at stereotaxic coordinates A24.3,
L-3.0, V21.4 of the atlas by Paxinos and Watson [37], following
the protocol described by Slipczuk et al. [38]. The cannulae were
fixed to the skull and immobilized with dental acrylic. Animals
were allowed to recover from surgery for three days. Cannulated
rats received daily infusions of 1 ml 15 min before IH exposure.
The neutralizing anti-RAGE and anti-S100B antibodies or control
IgG were diluted to working concentration (0.5 mg/mL) with sterile
PBS. The NF-kB blocker sulfasalazine was diluted to a working
solution (1.25 mM) with sterile PBS from a DMSO-based stock
solution. Infection with the HSV-derived amplicon was achieved
by a unique intra-hippocampal injection of the defective virus
expressing the desired construct. Animals were exposed to IH two
days later to allow maximal construct expression.
Fixation
Animals were deeply anaesthetized with ketamine/xylazine (90/
10 mg/kg, ip) and were perfused through the left ventricle, initially
with saline solution containing 5000 UI of heparin and subse-
quently with a fixative solution containing 4% w/v paraformal-
dehyde in 0.1 M phosphate buffer, pH 7.2. Following delivery of
300 mL of fixative solution through a peristaltic pump, brains
were removed and kept in cold fixative solution for 2 h. Brains
were then washed three times in cold 0.1 M phosphate buffer
pH 7.4 containing 5% (w/v) sucrose, left in washing solution for
18 h at 4uC and then washed in 0.1 M phosphate buffer pH 7.4
containing 30% w/v sucrose as cryoprotective. Then, brains were
rapidly frozen at280uC for 3 h and stored at220uC. Coronal 50-
mm-thick brain sections were cut using a cryostat. Sections were
cryoprotected by immersion in a solution containing 30% (v/v)
ethylene glycol and 20% (v/v) glycerol in 0.1 M phosphate buffer
pH 7.4 at 220uC. Cultured cells were fixed as previously
described in Villarreal et al [29]. Briefly, cells were washed with
cold phosphate-buffered saline (PBS) and fixed with 4% parafor-
maldehyde plus 4% sucrose in PBS pH 7.2 for 15 min at 18–
25uC.
Immunohistochemistry and immunofluorescence
Brain sections of animals from all experimental groups were
simultaneously processed in the free floating state as previously
described [11]. All antibodies were diluted in a solution with
phosphate-buffered saline (PBS), 1% Triton X-100 and 3%
normal goat serum. Development of peroxidase activity was
carried out with 0.035% w/v 3,39 diaminobenzidine plus 2.5% w/
v nickel ammonium sulfate and 0.1% v/v H2O2 dissolved in
acetate buffer 0.1 M pH 6.0. Controls for the immunohistochem-
istry procedure were routinely performed by omitting the primary
antibody; control sections did not develop any immunohistochem-
ical labeling. Double fluorescent immunostaining studies were
performed essentially in the same way, but the endogenous
peroxidase inhibition was omitted and isotypic specific secondary
antibodies (Jackson ImmunoResearch, West Grove, PA, USA)
labeled with FITC or Rhodamine RRX were used in a 1:800
dilution. Nuclear counterstaining was done with Hoechst 33342
(2 mg/ml). For immunocytochemistry, fixed cell cultures were
washed three times with cold PBS and permeabilized with 0.1%
Triton X-100. The procedure was then followed as stated for tissue
sections using the indicated dilutions of the primary antibodies:
GFAP 1:5000, bIII-Tubulin 1:5000, p65NLS 1:1000. Digital
photographs were taken in an Olympus IX-81 microscope
equipped with a DP71 camera (Olympus, Tokyo, Japan) or in a
Zeiss Axiophot (Carl Zeiss, Oberkochen, Germany) microscope
equipped with a digital camera (Olympus Q5). Confocal images
were taken in an Olympus FV-1000 confocal microscope.
Thiobarbituric Acid Reactive Substances (TBARS) assay
Immediately after IH exposure, rats were deeply anaesthetized
and sacrificed by decapitation. Hippocampi were dissected and
homogenized in cold buffer containing K2HPO4/KH2PO4
30 mM, KCl 120 mM, pH 7.4 and 10% (v/v) butylated
hydroxytoluene (BHT) 4% in ethanol was added as antioxidant.
Primary cell cultures were lysed within the same buffer immedi-
ately after finishing IH exposure. A 100 ml aliquot of hippocampal
or cell homogenate was added to 200 ml of 0.1 N HCl, 30 ml 10%
(w/v) phosphotungstic acid and 100 ml of 0.7% (w/v) 2-
thiobarbituric acid. The mixture was heated in boiling water for
60 min. TBARS were extracted in 1 mL of n-butanol. After a
brief centrifugation, the fluorescence of the butanolic layer was
measured in a Hitachi F-3010 spectrophotometer at 515 nm
(excitation) and 553 nm (emission). A calibration curve was
prepared using 1,1,3,3-tetramethoxypropane as standard. Results
were expressed as pmol of TBARS per mg of protein and
normalized to the control TBARS level [39].
RT-PCR
RT-PCR was performed as previously described in Ramos et al
[40]. Brains from IH exposed animals were dissected, hippocam-
pal tissue extracted and mRNA was isolated using the RNAeasy
Mini kit, according to the manufacturer’s instructions (Qiagen,
Hilden, Germany). cDNA was generated using the Omniscript RT
kit (Qiagen) with random hexamers (Roche Products), and PCR
was performed using specific primers for IkBa (forward 59-
GCAATCATCCACGAAGAGAAGCC-39, reverse 59-TTACC-
CTGTTGACATCAGCCCC -39), XIAP (forward 59-TGGTCA-
GAACACAGGAGACACTTTC-39, reverse 59- CACTTCAC-
TTTATCGCCTTCACC-39) or BclXL (forward 59- AGTAA-
ACTGG GGTCGCATCGTG-39, reverse 59- GTAGTGG-
TTCTCCTGGTAGCAATGG-39). Detailed PCR protocols are
available from authors under request. PCR products were run in a
1.5% agarose gel and photographed in a Bio-Rad (Hercules, CA)
VersaDoc 4000 imaging system. Each RT-PCR experiment was
run with negative controls, in which Omniscript reactions were
performed in the absence of reverse transcriptase; the negative
controls consistently failed to generate a PCR product. Quanti-
tative analysis of gel images was done with the ImageJ software.
b-Galactosidase assays
Fixed brain sections were assayed for b-galactosidase activity as
previously described in Bhakar et al. [34]. Briefly, sections were
incubated at 37uC in 80 mM dibasic sodium phosphate, 20 mM
monobasic sodium phosphate, 2 mM MgCl2, 0.2% Nonidet P-40,
1 mg/ml sodium deoxycholate, 5 mM potassium ferricyanide,
5 mM potassium ferrocyanide, and 800 mg/ml 4-chloro-5-bromo-
3-indolyl-b-galactoside for 4–16 hr. Samples were then washed in
PBS and post-fixed in 4% paraformaldehyde in PBS.
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Viral vector production
Amplicon plasmids. Plasmids were constructed carrying
either RAGEwt, RAGE-Dcyto or pcDNA3 backbone (control).
The pcDNA3-RAGEwt and pcDNA3-RAGEDcyto plasmids
(kindly provided by H. Huttunen, Neuroscience Center, Univer-
sity of Helsinski) were digested with KpnI, blunt-ended and
digested with XbaI. The RAGE containing sequences were cloned
into the NheI-blunt and XbaI ended sites of amplicon plasmid pA-
EUA2 [41] to generate the RAGE-expressing amplicon plasmids.
It is noteworthy that all amplicon plasmids also express GFP
reporter gene from an independent transcription unit.
Amplicon vectors. Amplicon vector stocks were prepared as
already described, using the amplicon plasmids, and the highly
neuroattenuated HSV-1LaLDJ virus as helper [41,42]. Briefly, 7b
cells, which are Vero cells expressing HSV-1 ICP4 and ICP27
proteins [43], were independently transfected with 5 mg of each
amplicon plasmid using Lipofectamine Plus (Invitrogen). One day
later, transfected cells were superinfected at a multiplicity of
infection of 0.3 plaque forming unit (PFU) per cell, with HSV-
1LaLDJ as helper virus. When cytopathic effect was maximal, cells
were collected by centrifugation, disrupted by three freeze/thaw
cycles to release vector stocks, and re-centrifuged at 1000 g for
10 min to pellet the cell debris. Helper and vector particles in the
supernatants were then titrated as already described [41,44]. Cells
expressing fluorescent GFP were scored directly under an inverted
fluorescence microscope (Olympus, Tokyo, Japan). Titers of the
different amplicon vector stocks ranged from 16106 to 46107
transducing units (TU) per ml.
Morphometric analysis
In order to ensure objectivity all measurements were performed
on coded slices. GFAP immunostained area and feature assess-
ment of astroglial cells, morphometric parameters of bIII-Tubulin
stained neurites, features of NeuN stained neuronal cells counts
and p65NLS stained cells were performed using the NIH ImageJ
software. For immunohistochemistry, images taken with the
microscope were captured with the digital camera, transformed
to 8-bits gray scale, normalized and an interactive threshold
selection was carried out. Once the threshold was determined it
was kept fixed for the entire experiment. For the analysis of
neuronal alterations and NeuN staining, counting was done
interactively discriminating the type of labeling observed in the
neuronal nuclei. Quantification of NeuN+ neurons was performed
by dividing the population into two categories: normal staining
(intense NeuN+ nucleus plus light cytoplasm) and abnormal
staining (spongiform nuclear NeuN+ staining or cells showing
NeuN+ cytoplasmic staining with nuclear NeuN negligible
staining) as previously described [11] In all cases (neuronal or
glial markers), approximately 10–15 fields per tissue section per
treatment per anatomical area (hippocampus, cortex) and marker
were analyzed. Sections coming from six to eight animals per
treatment were analyzed. For the in vitro morphology studies, glial
cells were divided into three populations: Filamentous astrocytes
(with long prolongations and small perinuclear soma), polygonal
astrocytes (big soma without prolongations) and intermediate
astrocytes (combination of both morphologies). For length
quantification of the beta-3-tubulin immunoreactive neuronal
projections, the NeuronJ plug-in of the ImageJ software (National
Institutes of Health) was used. The mean total neurite length per
neuron was calculated for each microscopic field and referred to
the control values to render a relative measurement.
Statistical analysis
Experiments and measurement were done 3–4 times showing
identical results. Data were normalized and presented as pooled
data in the graphs. Statistical comparisons were analyzed with
one-way ANOVA and Student-Newman-Keuls post-test, or two-
way ANOVA and Bonferroni post-test (as described in each case)
using GraphPad Software (GraphPad Software Inc., San Diego,
CA, USA).
Results
In vitro IH exposure parallels the increase in ROS,
neuronal alterations and reactive gliosis observed in vivo
Experimental models of SA using the IH paradigm have
demonstrated that increased oxidative stress is a crucial compo-
nent of the SA pathophysiology, and that antioxidants are useful to
prevent neuronal alterations [22,36]. In the experimental para-
digm of in vivo IH exposure, which reproduces the oxygen
saturation in haemoglobin levels found in patients [11], we
observed that TBARS level is significantly increased after 3 days of
IH exposure (Figure 1A). When this parameter was studied in
dissociated mixed hippocampal cell cultures, we found that 8
cycles of IH exposure were able to reproduce the magnitude of the
TBARS increase observed in vivo (Figure 1B).
Animals exposed to IH have shown signs of neurodegeneration,
as evidenced by relocalization of NeuN neuronal nucleus marker
and shorter neuronal projections, as well as by a significant
reactive gliosis [11]. Exposure of dissociated mixed hippocampal
cell cultures to 8 cycles of IH induced a similar reduction in neurite
extension (Figure 1C, D). IH also induced a reduction in the
number of polygonal astrocytes, together with an increase in the
abundance of cells in the fibrillar phenotype, a phenomenon
known as stellation and considered to be the in vitro correlation of
reactive gliosis (Figure 1E, F).
IH exposure activates the NF-kB pathway
We have previously shown increased RAGE expression and
overexpression of the RAGE ligand S100B in animals exposed to
IH [11]. Since RAGE canonically activates NF-kB mediated
downstream signalling, our next question was whether NF-kB was
activated after IH exposure. For that purpose animals were
exposed to the IH paradigm for 3 or 5 days and then RT-PCR
assays for several NF-kB target genes were performed in samples
obtained from hippocampal tissue. As shown in Figure 2A, IkB,
Bcl-XL and XIAP, all of them NF-kB target genes, were increased
after IH exposure. To verify if the increase in these target mRNAs
correlates with increased NF-kB transcriptional activity, transgenic
mice expressing an NF-kB-LacZ reporter gene were exposed to
IH, and LacZ expression was detected in tissue sections by
histochemistry. As shown in Figure 2B, hippocampal NF-kB
-induced transcriptional activity was significantly increased in IH
exposed animals and presented a peak at IH3. In agreement with
these results, astrocytes and neurons from the hippocampal mixed
cultures also showed increased nuclear p65NLS immunoreactivity
after IH exposure (Figure 2C, 2D), thus indicating activation of
the NF-kB signalling.
S100B blockage reduces reactive gliosis after IH exposure
S100B has been recently recognized as a DAMP released by
astrocytes after acute or chronic brain injury, and it is a known
RAGE ligand. S100B levels are increased in SA patients [32,33]
and its expression is induced in experimental models of SA
[11,12]. To study S100B role in the neuronal and glial alterations
observed after IH, we blocked S100B using neutralizing antibodies
RAGE/NF-kB Pathway in Sleep Apnea
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in dissociated mixed hippocampal cell cultures and in animals
exposed to IH.
As shown in figure 3A, S100B blockage abolished the astrocytic
stellation induced by 8 cycles of IH in mixed hippocampal cell
culture but significantly increased stellation in normoxic condi-
tions. S100B neutralizing antibodies failed to significantly prevent
the reduction of neurite length induced by IH in vitro (Figure 3B).
In agreement with this result, S100B neutralizing antibodies
administrated intra-hippocampally were unable to prevent the
neuronal degeneration induced by 3 days of exposure to IH in
animals (Figure 3C). This S100B blockage was, however, able to
partially reduce astroglial hypertrophy in animals exposed to IH
(Figure 3D). Similarly, as it was previously shown in vitro, S100B
blockage in normoxic conditions induced reactive gliosis in
animals from the normoxic group (Figure 3D).
Figure 1. IH-exposed dissociated mixed hippocampal cell culture reproduces several features of in vivo IH exposure. A: Relative
TBARS content in the hippocampus of animals exposed to normoxia (Nox) or to IH for 3, 5 or 10 days (IH3, IH5, IH10). B: Relative TBARS content in the
dissociated mixed hippocampal cell culture exposed to normoxia (Nox) or to 2, 5, or 8 cycles of IH (IH2c, IH5c, IH8c). C: Beta-3-tubulin immunostained
hippocampal neurons in the dissociated mixed hippocampal culture exposed to normoxia (Nox) or 8 cycles of IH (IH8c), bar = 20 mm. D: Quantitative
analysis of the relative neurite length in the hippocampal neurons in the mixed culture exposed to normoxia (Nox) or 8 cycles of IH (IH8c). E: GFAP
immunostained astrocytes in the dissociated mixed hippocampal culture exposed to normoxia (Nox) or 8 cycles of IH (IH8c), bar = 23 mm. F:
Quantitative analysis of astroglial stellation followed by the phenotypic change in the GFAP-immunoreactive astrocytes after 2, 5, or 8 cycles of IH
(IH2c, IH5c, IH8c). Data on the graphs are shown as means 6SEM; significance vs. control group was represented as indicated: * p,0.05; **p,0.01;
*** p,0.001 after one way ANOVA and Student Newman Keuls post-test.
doi:10.1371/journal.pone.0107901.g001
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RAGE blockage reduces neuronal alterations and reactive
gliosis after IH exposure
RAGE is a pattern recognition receptor that can be activated by
DAMP proteins released after brain injury, including glial S100B.
RAGE engagement by its ligands leads to increased NF-kB
activity and innate immunity activation. In order to study whether
RAGE activity is required for the neuronal and glial alterations
observed after IH exposure, two different approaches were
implemented for the loss of function studies; RAGE blocking
antibodies were used to neutralize endogenous RAGE and a HSV-
derived amplicon vector expressing a dominant negative RAGE
(RAGEDcyto) unable to bind intracellular adaptor proteins was
used to compete by sequestering endogenous RAGE ligands. For
the gain of function studies, an HSV-derived amplicon bearing a
full length RAGE (RAGEwt), was used.
As shown above, exposure to IH significantly reduced neurite
length in hippocampal cultured neurons from mixed culture. This
detrimental effect was prevented by incubation with anti-RAGE
neutralizing antibodies (Figure 4A). Similarly, IH exposure
induced astrocyte stellation, and RAGE blockage efficiently
prevented this effect as well (Figure 4B). Astrocytes infected with
the HSV-derived amplicon expressing RAGEDcyto, but not with
the amplicon bearing the control construct, were also resistant to
IH-induced stellation (Figure 4C).
We then analyzed if the RAGE blockage was also able to reduce
neuronal alterations and reactive gliosis induced by IH exposure in
vivo. For that purpose, animals were cannulated unilaterally and
RAGE blocking antibodies, or the unrelated control IgG, were
infused before exposing animals to the IH cycles. This procedure
was repeated every day, 15 min before initiating IH exposure. In
agreement with our previous results, IH exposure reduced
neuronal survival, an effect that was evidenced by atypical
localization of NeuN and shorter neurite projections on animals
that received control antibodies (Figure 5A and [11]). The infusion
of RAGE blocking antibodies reduced the number of abnormal
neuronal nuclei (i.e. those showing absence of NeuN staining in
the nucleus and relocalization to the cytoplasm) in animals
exposed to IH, but surprisingly, RAGE blockage was detrimental
in normoxic conditions (Figure 5A). On the other hand, IH
exposure also induced a profuse reactive gliosis as previously
described [11] and infusion of RAGE blocking antibodies
efficiently prevented reactive gliosis induced by IH, but caused
reactive gliosis per se in normoxic conditions (Figure 5B). Infection
with the amplicon bearing the sequence of RAGEDcyto also
reduced the neuronal loss induced by IH exposure, while
RAGEwt overexpression increased neuronal alterations in IH
exposed animals (Figure 5C).
Inhibition of NF-kB transcriptional activity improves
neuronal survival and reduces reactive gliosis after IH
exposure
NF-kB transcriptional activity response was reported to be
increased in the periphery in SA patients [45–47]. The generic
downstream response after RAGE engagement with its ligands is a
higher NF-kB transcriptional activity. Since we have shown that
increased RAGE expression and activity render in reactive gliosis
and neuronal alterations after IH, our next question was whether
NF-kB was required for those effects. For that purpose, and to
further dissect the molecular pathways involved in the observed
neuroglial effects, we blocked NF-kB activity in vitro and in vivo
after exposure to IH.
Dissociated mixed hippocampal cell cultures were treated with
the NF-kB chemical blocker BAY117082, and then exposed to the
IH cycles. As shown in Figure 6A, astrocytic stellation induced by
IH exposure was abolished by BAY117082 treatment. However,
blockage of NF-kB showed a tendency to increase stellation in
normoxic cultures (Figure 6A). Animals which were exposed to IH
and received the chemical NF-kB blocker sulfasalazine showed an
increase in neuronal survival, compared to those receiving vehicle
(Figure 6B). Interestingly, blockage of NF-kB induced a reduction
in neuronal survival in normoxic conditions (Figure 6B). The
effectiveness of the NF-kB blockage by sulfazalazine was evaluated
by studying nuclear localization of NF-kB p65 subunit. Sulfaza-
lazine treatment abolished the increased p65 nuclear localization
induced by IH exposure in vivo (Figure 6C).
Discussion
Experimental studies on rodents using IH exposure to mimic
human SA are accepted models for analyzing the neurobiological
basis of the cognitive alterations observed in human SA patients
[13,48]. These models are supported by the fact that structural
alterations have been observed in brains of IH-exposed animals, as
well as in diagnostic brain imaging in humans that suffer SA (see
for review [10]). Clinical and experimental evidence points
towards a predominant role of hippocampus in the cognitive
impairments observed in SA patients [10].
The dissection of molecular cascades and cellular events in SA
has been quite complex due to the absence of cellular in vitro
models useful for testing the participation of intracellular
mediators in SA. Such models would also be useful for testing
neuroprotective drugs before going into animal models. In this
work we have used the dissociated mixed hippocampal culture as
described by Parpura et al. [49] combined with the IH exposure
paradigm described by Shan et al. [36], and demonstrated that
eight cycles of IH in vitro produce a similar increase in oxidative
stress, as determined by TBARS abundance, to that observed in
animals exposed to experimental IH.
Figure 2. IH exposure activates NF-kB in vitro and in vivo. A: Animals were exposed to 3 or 5 days of IH and mRNA was isolated from
hippocampal tissue, reverse transcribed and subjected to PCR using primers directed against IkB, Bcl-XL, XIAP and actin. Optical density of the bands
was quantified with the ImageJ gel analyzer and related to the intensity of the actin bands. B: NF-kB reporter mice expressing an NF-kB reporter
minigene showed increased NF-kB activity after 3 days of exposure to IH (IH3) in the hippocampal CA-1 region (left); quantitative evaluation of X-gal
staining (right). NF-kB reporter minigene contains three tandem HIV-derived kB binding element repeats, placed proximal to a minimal promoter
derived from SV40, an E. coli b-galactosidase cDNA with a mammalial Kozak consensus, an SV40 T-antigen-derived nuclear localization signal, and a
polyA tract [34]. C: Immunocytochemistry for the p65 nuclear localization signal (p65NLS) in astrocytes of dissociated mixed hipocampal cell cultures,
bar = 20 mm (left), quantitative analysis (right) shows the percentage of GFAP+ cultured cells showing p65NLS nuclear staining after 8 cycles of IH
exposure (IH8c) or normoxia (Nox). D: Immunocytochemistry for the p65 nuclear localization signal (p65NLS) in neurons of the dissociated mixed
hipocampal cell culture, bar = 20 mm (left), quantitative analysis (right) shows the percentage of MAP2+ cells showing p65NLS nuclear staining after 8
cycles of IH exposure (IH8c) or normoxia (Nox). Data on the graphs are shown as means 6SEM; significance vs. control group was represented as
indicated: * p,0.05; **p,0.01; *** p,0.001 after one way ANOVA and Student Newman Keuls post-test.
doi:10.1371/journal.pone.0107901.g002
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Figure 3. S100B blockage reduced astroglial stellation in vitro and reactive gliosis in vivo. A: GFAP immunostained astrocytes in
dissociated mixed hippocampal cell cultures after 8 cycles of IH exposure (IH8c) in the absence or presence of S100B blocking antibodies (1 mg/ml),
bar = 23 mm (left). Percentage of filamentous astrocytes was evaluated in the same cultures using the ImageJ cell counter plugin and referred to the
total number of GFAP+ cells (right). B: Relative neurite length per neuron in the dissociated mixed hippocampal cell culture after 8 cycles of IH
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Over the last years it has been reported that acute necrotic
injuries, but also chronic mild injuries to the brain parenchyma,
induce the release of DAMP proteins capable of activating innate
immunity. Once in the extracellular milieu DAMPs interact with
pattern recognition receptors (PRR) like RAGE and receptors of
the toll-like family (TLR) to induce different responses, though
most of them share the common NF-kB downstream pathway.
Following PRR activation, NF-kB transcriptional activity induces
the expression of a plethora of genes related to the control of cell
survival, but several of them are directly involved in the
inflammatory response. While the participation of DAMP/PRR
cascade in acute pathological states like ischemia and traumatic
brain injury has been addressed, the question of whether these
molecules affect neuronal survival in SA remained to be cleared.
RAGE expression has been previously demonstrated to occur in
anatomical areas related to the behavioral alterations observed in
patients and animal models of SA [11,22]. On the other hand,
members of the S100 family have been recognized as DAMP
molecules capable of activating innate immunity [50]. In
particular, S100B, which has a glial origin, behaves as a glial-
specific DAMP being released after brain injury [51]. In SA
patients, S100B levels are increased [32,33,52,53], and we have
previously reported that S100B expression dramatically increased
in the animal model of SA [11]. Extracellular S100B interacts with
RAGE and leads to NF-kB activation [29,30].
We here used NF-kB reporter mice to demonstrate that this
transcription factor is transcriptionally active after IH exposure. In
agreement with this observation, the expression of some NF-kB
dependent genes (IkB, XIAP, Bcl-XL) is increased in the
hippocampus of rats exposed to IH cycles. These results correlate
with data showing that the NF-kB activity is increased in
circulating monocytes, endothelium, liver, heart and lungs in SA
patients [45–47,54] and supports the hypothesis of a pro-
inflammatory status as a crucial pathogenic contributor to SA
[55]. We observed that increased NF-kB activity is also present in
the brain of IH exposed animals and, more importantly, NF-kB
activity seems to be related to the neuronal and glial alterations
observed after IH exposure. By using dissociated mixed hippo-
campal cell culture, a setting that contains all the cellular elements
(glia and neurons) present in the hippocampus, we observed that
NF-kB activity is increased in neurons and glial cells, being the
latter probably responsible for the increased pro-inflammatory
activity.
Reactive gliosis is a key component of the cellular response to
CNS injury and comprises several changes in astrocytes and
microglia. In particular, astrocytes suffer the transition from the
quiescent to the reactive astrocytic state, accompanied by an
increase in intermediate filaments, predominantly GFAP, leading
to an increase in soma size and metabolic processes (reviewed in
[56]). The beneficial or detrimental effects of reactive gliosis are
still a matter of debate, but it is clear enough that the astroglial
conversion to the pro-inflammatory phenotype induces neuronal
degeneration and death [28].
In order to establish the role of the S100B/RAGE/NF-kB
pathway in the reactive gliosis and neuronal alterations observed
in the animal model of SA, we performed in vitro and in vivo loss
of function studies on each member of the cascade.
By using S100B blocking antibodies, we observed that neuronal
survival after IH was not modified by reducing S100B biological
activity. However, reactive gliosis was significantly reduced in the
same paradigm both in vitro and in vivo. This result is in
agreement with the idea that S100B is an autocrine factor that
may induce a conversion of astrocytes to the reactive phenotype
[30,31]. Our results also showed that S100B blockage in normoxic
conditions induces reactive gliosis in absence of injury. This
interesting result is not surprising if we consider that S100B is
constitutively secreted by astrocytes in the healthy brain, probably
acting as an autocrine glial communication molecule. Accordingly,
an S100B basal level is expected to occur in the intact CNS, acting
as an autocrine system connecting astrocytes; thus, a reduction or
suppression of such activity could be interpreted as a stress signal
by the astrocytes.
We then studied the next step in the signaling pathway. RAGE
blockage with neutralizing antibodies prevented the IH-induced
neurite shortening in vitro and the reduced neuronal survival in
vivo. By using the dominant-negative RAGE (RAGEDcyto) we
also found less neuronal loss in vivo after IH exposure.
Concomitantly, full-length RAGE over-expression reduced neu-
ronal survival. These results indicate that RAGE signaling is
necessary to induce neuronal degeneration in this IH paradigm.
An increased activity of RAGE-dependent signaling has been
related to neuronal degeneration and death, with mechanisms
involving reactive oxygen species [57] and NF-kB dependent pro-
apoptotic [29,58] or pro-inflammatory genes [59]. It is tempting to
speculate that this latter possibility has a correlation with the fact
that we have found in this work that reactive gliosis is blunted by
RAGE blockage in vitro and in vivo. Blockage of RAGE signaling
seems to partially prevent astroglial conversion into the pro-
inflammatory phenotype, which induces neurodegeneration [28]
Intriguingly, S100B or RAGE blockage efficiently reduced
reactive gliosis in IH but only RAGE blockage reduced IH-
induced neuronal degeneration. This fact points out towards the
multiligand capacity of RAGE and the presence of other DAMP
able to bind RAGE in vivo after IH exposure, being HMGB-1 a
candidate for this role. Indeed, HMGB-1 was reported to be
increased in the serum of SA patients and was shown to be
reduced after CPAP treatment [60]. Although RAGE is not
detectable in the adult brain, RAGE blockage in vivo was
detrimental for neuronal survival and induced reactive gliosis in
normoxic conditions. Apparently, a certain level of RAGE basal
signaling is required for neuronal survival and/or for preserving
astrocytes in the quiescent stage. One hypothesis is that RAGE is
undetectable but present in the adult CNS, and that a low basal
RAGE signaling is required in the healthy CNS. In fact RAGE
mRNA has been detected in the intact brain and blood vessels
endothelium [61]. Another possible explanation is that RAGE
blockage in circulating macrophages present in the CNS
capillaries induces the secretion of cytokines that activate
astrocytes and microglia. The requirement of low basal signaling
exposure (IH8c) in the absence or presence of S100B blocking antibodies. C: NeuN immunostaining of hippocampal CA-1 region in cannulated
animals that received S100B neutralizing antibodies and were exposed to three days of IH cycles (IH3), bar = 40 mm (left). Quantitative analysis of the
percentage of neuronal survival (i.e. those neurons showing normal NeuN staining) in sections obtained from these animals (right). D: GFAP
immunostaining of astrocytes in the hippocampal CA-1 region in cannulated animals that received S100B neutralizing antibodies and were exposed
to three days of IH cycles (IH3) or normoxia (Nox), bar = 40 mm (left). Quantitative analysis of the percentage of the area covered by GFAP-
immunoreactive cells (right) is used to evidence increased area occupied by hypertrophied reactive astrocytes. Data on the graphs are shown as
means 6SEM; significance vs. control group was represented as indicated: * p,0.05; **p,0.01; *** p,0.001 after two-way ANOVA and Bonferroni
post-test.
doi:10.1371/journal.pone.0107901.g003
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Figure 4. RAGE is required for the neuronal alterations and astroglial stellation induced by IH exposure in the dissociated mixed
hippocampal cell culture. A: bIII-Tubulin immunostained hippocampal neurons in dissociated mixed hippocampal cell culture after 8 cycles of IH
exposure (IH8c) or normoxia (Nox) in the absence and presence of RAGE blocking antibodies (1 mg/ml), bar = 14 mm (left). Quantitative analysis of
relative neurite length per neuron in a similar experiment (right). B: GFAP immunostained astrocytes in dissociated mixed hippocampal cell culture
after 8 cycles of IH exposure (IH8c) or normoxia (Nox) in the absence or presence of RAGE blocking antibodies, bar = 14 mm (top). Quantitative
analysis of the percentage of filamentous astrocytes (bottom). C: Astrocytes infected with the HSV-derived amplicon driving the expression of
RAGEDcyto and GFP, or control amplicon expressing only GFP, exposed to 8 cycles of IH exposure (IH8c) or normoxia (Nox), bar = 12 mm. Data on the
graphs are shown as means 6SEM; significance vs. control group was represented as indicated: * p,0.05; **p,0.01; *** p,0.001 after two way
ANOVA and Bonferroni post-test.
doi:10.1371/journal.pone.0107901.g004
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to PRR like RAGE and TLR to maintain certain essential
neuronal processes like plasticity is starting to be recognized [62].
RAGE and TLR signaling share the downstream NF-kB
dependent transcriptional activity; the last step of the signaling
pathway investigated in this work. We found that NF-kB blockage
successfully reduced the reactive gliosis induced by IH in vitro, and
prevented neuronal death induced by IH exposure in vivo. NF-kB
blockage efficiently reduced p65 NF-kB nuclear localization
induced by IH exposure. In normoxia, NF-kB blockage was
detrimental and induced reactive gliosis and neuronal degenera-
tion. These results are in agreement with the dual role of NF-kB,
by which over-activation induces neuronal death and a pro-
inflammatory response in astrocytes and microglia [29]; but
certain level of NF-kB activity is required for neuronal survival
[34]. An increased NF-kB activity was reported in SA patients in
different studies performed on the periphery, including circulating
Figure 5. RAGE is required for the neuronal alterations and reactive gliosis induced by IH in vivo. NeuN (A) or GFAP (B)
immunostaining in the hippocampal CA-1 region of animals exposed to IH for three days (IH3) and treated with intrahippocampal
administrations of RAGE blocking antibodies or control IgG, bar = 40 mm. Graphs on the right show the quantitative analysis of the
percentage of neuronal survival and of the area covered by GFAP-immunoreactive cells. C: Confocal images of animals that were infected with the
HSV-derived amplicon driving the expression of RAGE (RAGEwt), RAGEDcyto or empty sequence and were exposed to IH for three days, bar = 15 mm.
Data on the graphs are shown as means 6SEM; significance vs. control group was represented as indicated: * p,0.05; **p,0.01; *** p,0.001 after
two way ANOVA and Bonferroni post-test.
doi:10.1371/journal.pone.0107901.g005
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Figure 6. NF-kB is required for astroglial stellation and neuronal alterations induced by IH. A: Astroglial GFAP immunostaining in the
dissociated mixed hippocampal cell culture after 8 cycles of IH exposure (IH8c) or normoxia (Nox) treated with the NF-kB chemical blocker
BAY117082 (2 mM) or vehicle, bar = 30 mm. The graph shows the quantitative analysis of the percentage of filamentous astrocytes in a similar
experiment. B: NeuN immunostaining in the hippocampal CA-1 region of animals exposed to IH for three days (IH3) and treated with
intrahippocampal administrations of sulfasalazine (SFZ), an NF-kB chemical blocker, or vehicle, bar = 40 mm. The graph shows the quantitative
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monocytes, endothelium, liver, heart and lungs [45–47,54]. Here
we show that NF-kB is also over-activated in the CNS following
IH, but more importantly, that either NF-kB blockage or a
decreased RAGE signaling reduces neuronal degeneration and
reactive gliosis, thus demonstrating that RAGE-NF-kB are
involved in the detrimental effects observed after IH exposure as
a model of SA.
Conclusions
Our results demonstrate that activation of the RAGE/NF-kB
pathway induces neuronal degeneration, while the S100B/
RAGE/NF-kB pathway induces reactive gliosis in the model of
SA by IH exposure. Thus, RAGE or NF-kB blockage facilitates
neuronal survival and reduces reactive gliosis in the experimental
model of SA. However, blockage of these pathways seems to be
detrimental in normoxic conditions. As a whole, our work shows
that control of PRR activity and NFkB transcriptional events are
obvious, but not unique, strategies for the development of
neuroprotective interventions to prevent neuronal death in SA.
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